NCT00321516View on ClinicalTrials.gov

Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Bipolar Disorder
Interventions
DRUG

aripiprazole

Tablets, Oral, 10, 20, or 30 mg (titrated), once daily, 14 days.

Trial Locations (4)

Unknown

Local Institution, Philadelphia

Local Institution, Austin

Local Institution, Bellaire

Local Institution, Desota

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00321516 - Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder | Biotech Hunter | Biotech Hunter